Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Exact Sciences

Cathie Wood Watch: Ark Again Pares DraftKings Stake

Wood’s flagship Ark Innovation ETF has lost 37% over the past year but has rebounded 23% so far this year.

The Street

Cathie Wood Watch: Ark Continues Coinbase Buying Spree

Wood's flagship Ark Innovation ETF has dropped 37% over the past year, but has rebounded 24% year to date.

The Street

Cathie Wood Watch: Ark Snags a Top Chipmaker, Pares Another

Ark Innovation ETF has slumped 38% over the past year and 75% from its February 2021 peak.

The Street

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Reverses Ahead Of Fed Minutes; Baidu Surges On Earnings; Nvidia Earnings On Deck

The Dow Jones reversed lower Wednesday ahead of minutes from the Federal Reserve's latest policy meeting. Nvidia earnings are due out late.

Investors Business Daily

Dow Jones Futures Rise: S&P 500 Nears Key Support As Nvidia Earnings Loom; Here's What To Do Now

The Nasdaq and S&P 500 have tumbled to just above critical support as Treasury yields spike. Nvidia earnings are on tap.

Investors Business Daily

Exact Sciences, A Top 5% Stock, Beat Quarterly Expectations

Exact Sciences delivered a second consecutive quarter of sales growth acceleration and EXAS stock rose on Wednesday.

Investors Business Daily

Cathie Wood Watch: Ark Bulks Up on Shopify, Pares 2 Other Stakes

Wood's flagship Ark Innovation has slid 34% over the past year and 74% from its February 2021 peak.

The Street

Read news from The Economist, FT, and more,
with one subscription

Cathie Wood Watch: Ark Buys Shopify, Pares Three Others

Wood's flagship Ark Innovation ETF has slipped 44% over the last year and 74% from its February 2021 high.

The Street

Cathie Wood Watch: Ark Buys Coinbase for Second Straight Day

Wood's flagship Ark Innovation ETF has sagged 44% over the past year, but has bounced back 35% so far this year.

The Street

Cathie Wood Watch: Ark Buys More Coinbase

Ark Innovation ETF slid 44% during the past year, but has rebounded 28% so far this year, joining the tech stock surge.

The Street

Cathie Wood Watch: Ark Lifts Coinbase Stake, Pares Nvidia

Wood's flagship Ark Innovation has slid 45% over the past 12 months but has rebounded 26% so far this year.

The Street

Cathie Wood Watch: Ark Continues to Shed a Big Holding

Wood's flagship Ark Innovation ETF has dropped 47% over the past year and 75% from its February 2021 peak.

The Street

Cathie Wood Watch: Ark Keeps Shedding Exact Sciences

Wood's flagship Ark Innovation ETF has slid 48% over the past year and 75% from its February 2021 peak.

The Street

Cathie Wood: Ark Continues Exact Sciences Dump

Ark Innovation ETF has slid 45% over the past year and 76% from its February 2021 peak.

The Street

Get all your
news in one place.

100’s of premium titles.
One news app.

The Street

Cathie Wood Watch: Ark Buys One Favorite, Dumps Another

Ark Innovation ETF has descended 48% over the past year and 77% from its February 2021 peak.

The Street

Cathie Wood Watch: Ark Unloads Some of a Favorite

Ark Innovation ETF has slid 47% during the past year and 76% from its February 2021 peak.

Investors Business Daily

Cathie Wood Is Crushing It This Year Thanks To 9 Stocks

Cathie Wood's ARK Innovation ETF is back — and back big. It's the top diversified ETF again this year so far, largely due to big winners.

The Street

Cathie Wood Watch: Ark Continues to Feast on Tesla Shares

Tesla is the No. 3 holding in her flagship Ark Innovation ETF, trailing only Exact Sciences and Zoom Video Communications.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review

The stock market rally picked up steam amid cooler inflation. Sharp Tesla price cuts and some notable earnings were in focus.

Investors Business Daily

Exact Sciences Raises Fourth-Quarter Estimates Above Expectations

EXAS stock jumped as the provider of cancer screening and diagnostic tests raised estimates for its fourth quarter.

Investors Business Daily

Exact Sciences Stock Scores Relative Strength Rating Upgrade

Exact Sciences shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

Stock Market Closes Near Day's Lows As S&P Falls Below Key Level On Recession Concerns

The stock market extended losses to a third day on low business activity and fears of a global recession. Facebook bucked the trend.

Investors Business Daily

Exact Sciences Rockets As Guardant's Blood Test Pales Vs. Cologuard

Guardant unveiled results for its colon cancer-detecting blood test that lagged rival Exact. GH stock crashed as EXAS stock jumped Friday.

Investors Business Daily

Cathie Wood Has Bet Big On These 10 Stocks; Here's How They Performed In 2022

Cathie Wood makes big bets on potential huge winners. But Ark Invest's top 10 holdings, including Tesla and Roku, tumbled in 2022.

Investors Business Daily

Exact Sciences Surges After Massively Beating Quarterly Forecasts, Raising Outlook

Exact Sciences massively beat third-quarter expectations and raised its full-year outlook — and EXAS stock skyrocketed on Friday.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.